Home » Topics » Regulatory » EMA

EMA
RSS

Regorafenib recommended for approval in Europe for GIST

June 30, 2014

Vertex receives positive CHMP opinion to expand Kalydeco approval

June 30, 2014

EMA accepts Ravicti MAA

June 26, 2014

EMA's COMP adopts positive opinion on marizomib in multiple myeloma

June 25, 2014

FDA and EMA accept applications for AbbVie's HCV regimen

June 17, 2014

European orphan drug designation awarded to Betalutin for follicular lymphoma

June 12, 2014

EMA validates MAA for Raxone in Leber's hereditary optic neuropathy

June 6, 2014

EMA grants accelerated assessment to nintedanib MAA for IPF

June 5, 2014

EMA accepts Hetlioz MAA for review

June 4, 2014

EMA's CHMP confirms negative opinion for RLX-030

May 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...